Continuous glucose monitor and coaching for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 2 diabetes for at least one year
- You take at least one diabetes pill (not insulin)
- You have a Sun Life group benefits plan and get your isCGM through Lumino Health Pharmacy, OR have private insurance and use standard blood sugar (CBG) monitoring
- You are willing to use the continuous glucose monitor for at least three months
- Your most recent HbA1c (blood sugar average) is 7.0% or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study tests if a personalized education program, supported by continuous glucose monitor (CGM) wear, can help adults with type 2 diabetes improve their blood sugar control. Participants will receive extra training and a CGM device to see how food, activity, and medications affect their glucose levels in real time.
This trial tests whether using continuous glucose monitor (CGM) data can help doctors and patients better manage type 2 diabetes. It is for people who already use insulin and a CGM device to check their blood sugar levels.
This study tests whether a team of community health worker and pharmacist can help improve blood sugar control in people with type 2 diabetes. You may be asked to use a continuous glucose monitor (a sensor that tracks sugar levels) and take part in support visits.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.